BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12460897)

  • 1. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.
    Sonoshita M; Takaku K; Oshima M; Sugihara K; Taketo MM
    Cancer Res; 2002 Dec; 62(23):6846-9. PubMed ID: 12460897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
    Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
    Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
    Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM
    Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
    Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
    Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis.
    Takeda H; Sonoshita M; Oshima H; Sugihara K; Chulada PC; Langenbach R; Oshima M; Taketo MM
    Cancer Res; 2003 Aug; 63(16):4872-7. PubMed ID: 12941808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of familial juvenile polyps expressing cyclooxygenase-2.
    Brazowski E; Rozen P; Misonzhnick-Bedny F; Gitstein G
    Am J Gastroenterol; 2005 Jan; 100(1):130-8. PubMed ID: 15654792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli.
    Spirio LN; Dixon DA; Robertson J; Robertson M; Barrows J; Traer E; Burt RW; Leppert MF; White R; Prescott SM
    Cancer Res; 1998 Nov; 58(21):4909-12. PubMed ID: 9809998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
    Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
    Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
    Chulada PC; Thompson MB; Mahler JF; Doyle CM; Gaul BW; Lee C; Tiano HF; Morham SG; Smithies O; Langenbach R
    Cancer Res; 2000 Sep; 60(17):4705-8. PubMed ID: 10987272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
    Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
    Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice.
    Vane J
    Jpn J Cancer Res; 1997 Nov; 88(11):inside front cover. PubMed ID: 9439674
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.
    Hull MA; Booth JK; Tisbury A; Scott N; Bonifer C; Markham AF; Coletta PL
    Br J Cancer; 1999 Mar; 79(9-10):1399-405. PubMed ID: 10188882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
    Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
    Takaku K; Wrana JL; Robertson EJ; Taketo MM
    Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COX and study of cancer therapy].
    Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1147-51. PubMed ID: 15332534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.